http://tickerreport.com/banking-finance/474507/roth-capital-initiates-coverage-on-mast-therapeutics-anx/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN
Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC Trial Sub-study will investigate effects of MST-188 on tissue oxygenation in sickle cell disease patients experiencing a vaso-occlusive...
Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell Disease MST-188 decreased a marker of inflammation and red blood cell aggregation (50% reduction relative to control) Data...
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc. - All-stock transaction - Conference call to discuss pending acquisition today at 8:30am Eastern Time PR...
Mast Therapeutics To Present At The Rodman & Renshaw 15th Annual Healthcare Conference On September 10 PR Newswire SAN DIEGO, Sept. 3, 2013 SAN DIEGO, Sept. 3, 2013 /PRNewswire/ -- Mast...
ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX" PR Newswire SAN DIEGO, March 11, 2013 SAN DIEGO, March 11, 2013 /PRNewswire/ -- ADVENTRX...
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX" Name and ticker symbol changes effective March 11, 2013 PR Newswire SAN...
Adventrx To Develop ANX-188 For Complications Of Arterial Disease - Seeking orphan drug designation in acute limb ischemia (ALI) - Phase 2 clinical proof-of-concept in ALI planned for late...
ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications - Platform includes over 100 pharmacology studies, 15 clinical studies and 2,500 patient exposures - ANX-188 phase...
ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4 PR Newswire SAN DIEGO, Feb. 25, 2013 SAN DIEGO, Feb. 25, 2013 /PRNewswire/ -- ADVENTRX Pharmaceuticals...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Symbol | Price | Vol. |
---|---|---|
SPXSDirexion Daily S&P 500 Bear 3X Shares New | $ 5.99 (-2.76%) | 81.54M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 29.59 (8.39%) | 79.33M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | $ 2.32 (-3.73%) | 70.29M |
SPYSPDR S&P 500 | $ 594.69 (0.60%) | 54.02M |
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | $ 3.24 (-6.76%) | 46.07M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.